Search Results

The risk of developing shingles—a virus that causes a painful, blistering skin rash—increases with age, especially in patients over 60. Zostavax, a single shot vaccine, is designed to help prevent adults from developing shingles for up to five years. Now in widespread use, the drug was approved by the U.S. Food and Drug Administration (FDA) in 2006. Unfortunately for patients, (more...)